We regret to state that incorrect images were uploaded in Fig. 3F, Fig. 3J, and Fig. 7C. The authors apologize for these errors. Correct images are as follows.

**Fig. 3.** Cell viability was determined by fluorescein diacetate-propidium iodide staining, in which viable cells were stained green and dead cells were stained red. (A--D) Staining of primary osteoblasts treated with ZXHA-TC at concentrations of 0 µg/mL, 6.25×10^−3^ µg/mL, 6.25×10^−2^ µg/mL, and 6.25×10^−1^ µg/mL at 2 days. (E--H) Staining of primary osteoblasts treated with ZXHA-TC at concentrations of 0 µg/mL, 6.25×10^−3^ µg/mL, 6.25×10^−2^ µg/mL, and 6.25×10^−1^ µg/mL at 4 days. (I--L) Staining of primary osteoblasts treated with ZXHA-TC at concentrations of 0 µg/mL, 6.25×10^−3^ µg/mL, 6.25×10^−2^ µg/mL, and 6.25×10^−1^ µg/mL at 6 days. (M) Statistical analysis of the data from the staining pictures from A--L (n=3). As time elapsed, more and more dead cells were found in each group. Comparatively, more viable cells were found in the ZXHA-TC--treated groups, which indicated the positive effect on the primary osteoblasts. Scale bar=200 µm.

**Fig. 7.** Time-course of ALP activity and ALP staining of primary osteoblasts at different concentrations (0 µg/mL, 6.25×10^−3^ µg/mL, 6.25×10^−2^ µg/mL, and 6.25×10^−1^ µg/mL) of ZXHA-TC are exhibited. (A) Relative ALP activity (units/100 mL) was expressed as mean±2 SD, and the activity in 6.25×10^−2^ µg/mL was significantly higher than other groups. ALP activity in the ZXHA-TC--treated groups increased from 2 to 4 days and decreased slightly from 4 to 6 days. However, the activity in the control increased over time. The bars with different letters at the same time are significantly different from each other (*p*\<0.05; n=3), and those with similar letters indicate no significant difference. (B--E) Staining of primary osteoblasts treated with ZXHA-TC at concentrations of 0 µg/mL, 6.25×10^−3^ µg/mL, 6.25×10^−2^ µg/mL, and 6.25×10^−1^ µg/mL at 2 days. (F--I) Staining of primary osteoblasts treated with ZXHA-TC at concentrations of 0 µg/mL, 6.25×10^−3^ µg/mL, 6.25×10^−2^ µg/mL, and 6.25×10^−1^ µg/mL at 4 days. (J--M) Staining of primary osteoblasts treated with ZXHA-TC at concentrations of 0 µg/mL, 6.25×10^−3^ µg/mL, 6.25×10^−2^ µg/mL, and 6.25×10^−1^ µg/mL at 6 days. ALP staining in the ZXHA-TC--treated groups was strengthened from 2 to 4 days and was weakened slightly from 4 to 6 days, and the concentration of 6.25×10^−2^ µg/mL performed best, which was in accordance the ALP activity results. Scale bar=200 µm. ALP, alkaline phosphatase.
